We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-1.4%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$45.6B
AUM Growth
-$2.97B
(-6.1%)
Cap. Flow
-$1.56B
Cap. Flow
% of AUM
-3.42%
Top 10 Holdings %
Top 10 Hldgs %
10.17%
Holding
4,085
New
718
Increased
950
Reduced
874
Closed
814
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$352M |
| 2 |
Kroger
KR
|
+$279M |
| 3 |
AT&T
T
|
+$235M |
| 4 |
Intel
INTC
|
+$217M |
| 5 |
Edwards Lifesciences
EW
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$461M |
| 2 |
Merck
MRK
|
+$459M |
| 3 |
Coca-Cola
KO
|
+$295M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$283M |
| 5 |
TSMC
TSM
|
+$264M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.08% |
| 2 | Technology | 16.14% |
| 3 | Healthcare | 15.45% |
| 4 | Consumer Discretionary | 9.74% |
| 5 | Consumer Staples | 5.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
US Bancorp
USB
$99.6B
| $74.7M | 0.16% |
1,852,886
+1,087,256
| +142% | +$50.3M |
|
127
Zscaler
ZS
$23B
| $74.6M | 0.16% |
453,939
+421,019
| +1,279% | +$68.9M |
|
128
Entegris
ENTG
$19.7B
| $74.5M | 0.16% |
897,235
-277,379
| -24% | -$27.1M |
|
|
BKI
129
DELISTED
Black Knight, Inc. Common Stock
BKI
| $72.8M | 0.16% |
1,125,439
+508,079
| +82% | +$33.5M |
|
130
Booking.com
BKNG
$138B
| $72.8M | 0.16% |
1,108,000
+1,055,900
| +2,027% | +$79.3M |
|
131
Bio-Rad Laboratories Class A
BIO
$8.42B
| $72M | 0.16% |
172,600
-52,169
| -23% | -$26M |
|
132
Verisk Analytics
VRSK
$26.4B
| $71M | 0.16% |
416,100
+41,506
| +11% | +$7.76M |
|
133
Graphic Packaging
GPK
$3.26B
| $70.2M | 0.15% |
3,555,214
-1,841,177
| -34% | -$40.4M |
|
134
American Express
AXP
$223B
| $69.2M | 0.15% |
+513,209
| New | +$77.7M |
|
135
Realty Income
O
$61.2B
| $69M | 0.15% |
+1,184,732
| New | +$81.7M |
|
136
Sensata Technologies
ST
$6.65B
| $68.7M | 0.15% |
1,844,013
+1,739,139
| +1,658% | +$72.9M |
|
137
CALL
Meta Platforms (Facebook)
META
$1.51T
| $67.5M | 0.15% |
+497,500
| New | +$80.6M |
|
|
138
UnitedHealth
UNH
$382B
| $66.8M | 0.15% |
132,332
-877,539
| -87% | -$461M |
|
|
BNY
139
Bank of New York Mellon
BNY
$108B
| $66.6M | 0.15% |
1,728,480
+861,031
| +99% | +$36.7M |
|
140
Progressive
PGR
$124B
| $66.4M | 0.15% |
+571,701
| New | +$68.8M |
|
141
Novartis
NVS
$295B
| $66.3M | 0.15% |
872,741
-44,958
| -5% | -$3.73M |
|
|
SPR
142
DELISTED
Spirit AeroSystems
SPR
| $65.9M | 0.14% |
3,005,135
-143,074
| -5% | -$4.35M |
|
143
Inspire Medical Systems
INSP
$1.42B
| $64.6M | 0.14% |
364,437
-5,666
| -2% | -$1.14M |
|
144
Spotify
SPOT
$99.2B
| $64.6M | 0.14% |
748,547
-59,335
| -7% | -$6.35M |
|
145
Jabil
JBL
$32.8B
| $63.8M | 0.14% |
1,105,426
+57,395
| +5% | +$3.34M |
|
146
CALL
Apple
AAPL
$4.89T
| $63.5M | 0.14% |
459,600
+396,400
| +627% | +$62.2M |
|
147
Consolidated Edison
ED
$41.6B
| $63.5M | 0.14% |
740,044
+367,856
| +99% | +$35.5M |
|
148
TripAdvisor
TRIP
$1.59B
| $63.4M | 0.14% |
2,873,585
+1,127,336
| +65% | +$25.3M |
|
|
TWTR
149
DELISTED
Twitter, Inc.
TWTR
| $63.3M | 0.14% |
1,444,730
-943,043
| -39% | -$38.4M |
|
150
Steris
STE
$20.9B
| $63.2M | 0.14% |
380,382
-509,843
| -57% | -$104M |
|
Similar funds
Marshall Wace's Q3 2022 Portfolio in Review
As of Q3 2022, Marshall Wace held 4,085 positions worth $45.6B, down 6.1% from $48.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Marshall Wace withdrew a net $1.56B in Q3 2022, closing 814 positions and reducing 874 holdings. Its most notable exit was General Dynamics, an estimated $122M position sold in full.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Marshall Wace opened a new position in Albertsons Companies worth $84.6M.
- Marshall Wace's largest Q3 2022 buy was Albertsons Companies: 3,404,097 shares worth $84.6M.
- Marshall Wace added most to JPMorgan Chase in Q3 2022, an estimated $352M increase.
- Marshall Wace's biggest Q3 2022 reduction was UnitedHealth, cutting an estimated $461M.
- Marshall Wace fully exited General Dynamics in Q3 2022, selling an estimated $122M.
- Marshall Wace's ten largest holdings make up 10% of its $45.6B portfolio in Q3 2022.
- Marshall Wace opened 718 new positions and closed 814 in Q3 2022.
- Marshall Wace's portfolio value fell 6.1% quarter-over-quarter to $45.6B.
Based on Marshall Wace's 13F filing for Q3 2022, filed 14 Nov 2022.